EVERYTHING ABOUT SEVITERONEL VT-464

-mutated tumors. Having said that, merely a portion of these sufferers responds to immune checkpoint or PARP inhibitors and also individuals that do react generally acquire resistance and relapse.Seviteronel (developmental codes VT-464 and, previously, INO-464) is definitely an experimental cancer medication and that is under advancement by Viamet